Shuhei Suzuki

9PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
Clotrimazole Targets the c-Myc-Survivin Axis to Reduce the Viability of Ovarian Cancer Stem Cells Alone and in Combination with Chemotherapeutic Agents.

|Feb 27, 2026
Genomic Landscape and Therapeutic Implications of Metaplastic Breast Carcinoma: Insights from a Nationwide Database Including Diagnostic Mimickers.

Shuhei Suzuki, Manabu Seino, Hidenori Sato

|Dec 24, 2025
Paclitaxel-Induced Collagenous Colitis: A Case Report in Male Breast Cancer.

Shuhei Suzuki, Hidekazu Horiuchi, Takanobu Kabasawa

|Nov 24, 2025
A Mucosal Change like Hypertrophic Gastritis Following Zolbetuximab-Based Therapy in a Conversion Surgery Case of Advanced Gastric Cancer.

Soshi Oyama, Shuhei Suzuki, Takanobu Kabasawa

|Aug 28, 2025
HDAC Class I Inhibitor Domatinostat Induces Apoptosis Preferentially in Glioma Stem Cells Through p53-Dependent and -Independent Activation of BAX Expression.

Yurika Nakagawa-Saito, Yasufumi Ito, Kazuki Nakamura

|Jul 29, 2025
Targeting Bcl-xL with Navitoclax Effectively Eliminates Senescent Tumor Cells That Appear Following CEP-1347-Induced Differentiation of Glioma Stem Cells.

Senri Takenouchi, Yasufumi Ito, Kazuki Nakamura

Pageof 2

Frequent Collaborators

3 joint publications

Koshi Takahashi

3 joint publications

Yurika Nakagawa-Saito

3 joint publications

Masashi Okada

2 joint publications

Yukihiko Sonoda